Law360, New York (October 07, 2009) -- Pharmaceutical giant Pfizer Inc. has hit German drugmaker Sandoz Inc. with a patent infringement suit alleging that Sandoz's abbreviated new drug application for a generic blood pressure and cholesterol reducer rips off the patented formula for Pfizer's Caduet.
In a complaint lodged Tuesday in the U.S. District Court for the District of Delaware, Pfizer urged the court to enjoin Sandoz from pursuing its ANDA for atorvastatin calcium tablets,...
